Author Correction To: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
CNS Drugs - United Kingdom
doi 10.1007/s40263-018-0510-z
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2018
Authors
Publisher
Springer Science and Business Media LLC